Logo

Description

Our Allopurinol bulk active pharmaceutical ingredient represents pharmaceutical excellence for buyers seeking reliable gout treatment raw materials. Sourced from an FDA-approved facility in Gujarat, this xanthine oxidase inhibitor API is available in multiple pharmacopeia grades including IP, BP, EP, USP, and injectable specifications. The product undergoes comprehensive quality control testing to ensure consistent purity, potency, and stability for pharmaceutical manufacturing applications. With ready stock availability and reliable supply chain management, we provide importers, distributors, and wholesalers with a trusted source for high-quality Allopurinol that meets global regulatory standards and manufacturing requirements.

Pharmaceutical manufacturers across multiple therapeutic areas utilize our Allopurinol API for developing gout management medications, anti-hyperuricemia treatments, and supportive therapies for cancer patients. The product serves rheumatology, nephrology, and...
Our Allopurinol bulk active pharmaceutical ingredient represents pharmaceutical excellence for buyers seeking reliable gout treatment raw materials. Sourced from an FDA-approved facility in Gujarat, this xanthine oxidase inhibitor API is available in multiple pharmacopeia grades including IP, BP, EP, USP, and injectable specifications. The product undergoes comprehensive quality control testing to ensure consistent purity, potency, and stability for pharmaceutical manufacturing applications. With ready stock availability and reliable supply chain management, we provide importers, distributors, and wholesalers with a trusted source for high-quality Allopurinol that meets global regulatory standards and manufacturing requirements.

Pharmaceutical manufacturers across multiple therapeutic areas utilize our Allopurinol API for developing gout management medications, anti-hyperuricemia treatments, and supportive therapies for cancer patients. The product serves rheumatology, nephrology, and oncology segments, with applications in chronic condition management and acute care settings. Industries value the consistent quality for formulating tablets, capsules, and injectables that require precise dosing and reliable bioavailability. Our API meets the growing global demand for uric acid control medications in aging populations and markets with increasing metabolic disorder prevalence.

Businesses choosing our Allopurinol benefit from supply chain reliability, regulatory compliance assurance, and consistent product quality. The product's multiple pharmacopeia certifications facilitate market entry for manufacturers targeting international distribution. Our established manufacturing expertise and ready inventory minimize production delays while ensuring product consistency across batches. This reliability translates to reduced quality risks, smoother regulatory approvals, and stronger market positioning for partners in the pharmaceutical supply chain.

Key Features:
- Multiple pharmacopeia compliance including IP, BP, EP, and USP grades
- FDA-approved manufacturing facility in Gujarat
- Ready stock availability for immediate shipment
- Consistent purity and potency across batches
- Injectable grade available for parenteral formulations

Benefits:
- Global regulatory acceptance and market access
- Reliable supply chain with minimal production delays
- Consistent quality for predictable manufacturing outcomes
- Multiple formulation options including injectables
- Trusted sourcing from certified manufacturing facility

Specifications

Additional Information
Country of OriginIndia

Application

Allopurinol API serves as a crucial xanthine oxidase inhibitor for pharmaceutical manufacturing, effectively controlling uric acid production in metabolic disorders. This bulk active ingredient is essential for developing gout management medications, hyperuricemia treatments, and chemotherapy support therapies worldwide. Its consistent purity and multiple pharmacopeia compliance make it ideal for tablet, capsule, and injectable formulations requiring precise dosing and reliable bioavailability. Pharmaceutical manufacturers utilize our Allopurinol API for chronic gout treatments, kidney stone prevention medications, and tumor lysis syndrome management drugs. The product meets stringent international standards including IP, BP, EP, and USP specifications, ensuring regulatory compliance across North American, European, and Asian markets. Manufacturers appreciate our consistent quality and ready stock availability for uninterrupted production schedules and timely market deliveries. - Tablet manufacturing for chronic gout treatment and management - Capsule production for hyperuricemia control medications - Injectable formulations for hospital-based tumor lysis syndrome care - Combination therapies for patients requiring diuretic treatments - Pharmaceutical preparations for metabolic disorder management

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

A. S. Joshi & Company, Maharashtra
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler•Importer / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Allopurinol API Bulk IP BP EP USP Injectable Gout Treatment

Allopurinol API bulk IP BP EP USP injectable grade from FDA-approved Gujarat facility for gout treatment medications and hyperuricemia management with reliable quality and ready stock availability.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

A. S. Joshi & Company
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler

More Products From Supplier